Artelo Biosciences, Inc.

Public

Artelo Biosciences, Inc. is now publicly traded

The data on this page reflects Artelo Biosciences, Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Seed Round

Mar 27, 2026

Total Funding Raised

$665,300

Company Overview

Artelo Biosciences, Inc. is a clinical-stage biopharmaceutical company that develops therapeutics targeting lipid-signaling pathways to treat cancer, pain, and other conditions.

AI Layer

Non-AI

Keywords

cancer-related anorexiacannabinoid receptor agonistclinical-stage biotechendocannabinoid systempharma cannabisdrug developmentlipid-signaling pathwayspharma licensingFABP5 inhibitorcancer anorexia-cachexia syndromeCACSneuropathic paincancer wastingchemotherapy-induced peripheral neuropathyCIPNCBD cocrystalcrypto on balance sheetSolana

Artelo Biosciences, Inc. Comparables

Compare Artelo Biosciences, Inc. with similar companies based on industry and business-model similarity.

Artelo Biosciences, Inc. comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Tensegrity Pharma, Inc.	63%
Receptor Life Sciences	57%
上海赛默罗生物科技有限公司	56%

View all Comparables

Artelo Biosciences, Inc. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed Round	Mar 27, 2026
Seed Round	Mar 27, 2026
Seed Round	Mar 27, 2026

View all Funding Rounds

Artelo Biosciences, Inc. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Artelo Biosciences, Inc. Filings

SEC and related filings with document metadata.

Firmographic Details

Headquarters—

Employee Range16

Year Founded2011

Last FundingMar 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?